Cullgen is a biopharmaceutical company that has developed protein degradation technology that utilizes the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Our technology, which we call uSMITE™ (ubiquitin-mediated, small molecule-induced target elimination) has the potential to address a broad range of intracellular disease targets, including those representing the up to 80% of proteins that cannot be addressed by existing small molecule therapies, commonly referred to as undruggable targets. In addition to using our uSMITE™ platform to build our own pipeline of protein degradation product candidates, we are also developing a portfolio of novel E3 ligands. You can learn more information about Cullgen on our website: www.Cullgen.com
View Top Employees from Cullgen Inc.Website | http://www.cullgen.com |
Employees | 29 (16 on RocketReach) |
Founded | 2018 |
Address | 12730 High Bluff Dr Suite 250, San Diego, California 92130, US |
Technologies |
JavaScript,
HTML,
Twitter
+4 more
(view full list)
|
Industry | Biotechnology Research, Biotechnology, Science and Engineering, Pharmaceutical, Health Care |
Looking for a particular Cullgen Inc. employee's phone or email?
Michael Plewe is the Senior Vice President - Medicinal Chemistry of Cullgen Inc..
16 people are employed at Cullgen Inc..
Cullgen Inc. is based in San Diego, California.